We are live on ! Find out more
NUVB icon

Nuvation Bio
NUVB

231 hedge funds and large institutions have $947M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

45% more call options, than puts

Call options by funds: $5.27M | Put options by funds: $3.64M

27% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 37

4% more funds holding

Funds holding: 223 → 231 (+8)

1.92% more ownership

Funds ownership: 61.7% → 63.62% (+1.9%)

44% less funds holding in top 10

Funds holding in top 10: 9 → 5 (-4)

50% less capital invested

Capital invested by funds: $1.89B → $947M (-$948M)

Holders
231
Holders Change
+8
Holders Change %
+3.59%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.06%
New
47
Increased
90
Reduced
58
Closed
37
Calls
$5.27M
Puts
$3.64M
Net Calls
+$1.63M
Net Calls Change
-$24.5M

Top Buyers

1
DFO
Duquesne Family Office
New York
+$25.3M
2
American Century Companies
American Century Companies
Missouri
+$15.9M
3
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
4
Citadel Advisors
Citadel Advisors
Florida
+$10.8M
5
AG
Algert Global
California
+$8.64M

Top Sellers

1
CFM
Capricorn Fund Managers
United Kingdom
-$14.2M
2
ACM
Abrams Capital Management
Massachusetts
-$14.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$13.4M
4
N
Nuveen
North Carolina
-$13M
5
SCP
SymBiosis Capital Partners
Arkansas
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$223M +$3.15M +564,612 +1%
DC
2
Decheng Capital
California
$111M – – –
BlackRock
3
BlackRock
New York
$108M +$2.4M +430,598 +2%
VCM
4
Vanguard Capital Management
Pennsylvania
$49.9M +$64.8M +11,626,198 New
OFM
5
Omega Fund Management
Massachusetts
$34.7M – – –
LCM
6
Laurion Capital Management
New York
$33.6M -$167K -30,000 -0.4%
State Street
7
State Street
Massachusetts
$29.1M +$5.16M +926,145 +16%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$25.2M +$843K +151,358 +3%
DFO
9
Duquesne Family Office
New York
$19.5M +$25.3M +4,539,800 New
Bank of America
10
Bank of America
North Carolina
$13.8M -$3.28M -589,599 -15%
RG
11
Redmile Group
California
$13.5M -$55.7K -10,000 -0.3%
TCM
12
Tang Capital Management
California
$13.5M -$3.94M -707,900 -18%
American Century Companies
13
American Century Companies
Missouri
$12.4M +$15.9M +2,860,262 +7,769%
Two Sigma Investments
14
Two Sigma Investments
New York
$11.5M +$10.9M +1,948,144 +265%
JHC
15
Jones Hill Capital
New York
$10.2M +$13.3M +2,383,031 New
VPM
16
Vanguard Portfolio Management
Pennsylvania
$9.76M +$12.7M +2,275,446 New
Citadel Advisors
17
Citadel Advisors
Florida
$8.86M +$10.8M +1,930,412 +1,430%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$8.81M -$76.2K -13,669 -0.7%
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$8.76M +$4.24M +761,413 +59%
Northern Trust
20
Northern Trust
Illinois
$8.59M +$453K +81,376 +4%
AQR Capital Management
21
AQR Capital Management
Connecticut
$8.56M +$1.82M +326,592 +20%
Charles Schwab
22
Charles Schwab
California
$8.55M -$135K -24,230 -1%
Goldman Sachs
23
Goldman Sachs
New York
$8.28M +$1.3M +233,940 +14%
Morgan Stanley
24
Morgan Stanley
New York
$8.03M +$3.32M +595,089 +47%
AG
25
Algert Global
California
$7.9M +$8.64M +1,550,970 +533%
1
2 3 4 5

NUVB Hedge Fund Activity: Q1 2026 in Review

231 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2026, worth a combined $947M — down 50% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new NUVB positions and 37 closed out — a net gain of 10 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $25.3M. The largest seller was Capricorn Fund Managers, exiting entirely with an estimated $14.2M sold.

  • 231 institutional investors held Nuvation Bio (NUVB) as of Q1 2026, up from 223 in Q4 2025.
  • Funds reported $947M of Nuvation Bio stock for Q1 2026, down 50% quarter-over-quarter.
  • 47 funds opened new Nuvation Bio positions in Q1 2026 and 37 closed out, a net change of +10 holders.
  • The largest Nuvation Bio buyer in Q1 2026 was Duquesne Family Office, an estimated $25.3M added.
  • The largest Nuvation Bio seller in Q1 2026 was Capricorn Fund Managers, an estimated $14.2M sold.

Based on aggregated 13F filings for Q1 2026.